NAS:MGNX (USA) Also Trade In: Germany
Macrogenics Inc $ 30.52 -0.16 (-0.52%)
Warning! GuruFocus has detected 3 Severe warning signs with MGNX. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for MGNX (Macrogenics) from 2013 to Jul 11 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Macrogenics stock (MGNX) PE ratio as of Jul 11 2020 is 0. More Details
Macrogenics PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Macrogenics PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:CYTK NAS:PHAT NAS:BEAM NAS:KNSA NAS:TBIO NAS:IMAB NAS:RVNC NAS:VCYT NAS:CHRS NAS:PTLA OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 9704 Medical Center Drive, Rockville, MD, USA, 20850
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. The company's strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The company's intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them.